.png){kind=small}
.png){kind=small}
BackTable / Urology / Podcast / Episode #139
Gynecologic-Sparing Cystectomy & More: Prioritizing Female Sexual Health
with Dr. Rachel Rubin and Dr. Sara Psutka
In this week’s BackTable Podcast, guests Dr. Sarah Psutka and Dr. Rachel Rubin join host Dr. Aditya Bagrodia to discuss the importance of considering women’s sexual health in urologic oncology surgeries.
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2023, November 29). Ep. 139 – Gynecologic-Sparing Cystectomy & More: Prioritizing Female Sexual Health [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Rachel Rubin
Dr. Rachel Rubin is a urologist and sexual medicine specialist in North Bethesda, Maryland.
Dr. Sara Psutka
Dr. Sara Psutka is an associate professor and urologic oncologist at UW in Seattle, Washington.
Dr. Aditya Bagrodia
Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.
Synopsis
The doctors go on to discuss how to ensure proper patient education and setting realistic expectations about post-surgery recovery. Additionally, they highlight the need for open conversation about sexual health and the use of hormone therapies to improve menopause symptoms. Finally, they touch on the need for more research in women’s sexual health and the use of pelvic floor physical therapy.
Timestamps
00:00 - Introduction
02:30 - The Importance of Open Conversations about Sexual Health
03:55 - Addressing Sexual Health in Cancer Patients
11:47 - The Role of Hormones in Women’s Health
25:05 - The Renewed Interest in Gynecologic Organ Sparing
29:39 - Importance of Risks and Oncologic Outcomes in Bladder Cancer Treatment
35:56 - The Role of Pelvic Floor Physical Therapy in Bladder Cancer Recovery
44:24 - The Role of Hormone Therapy in Bladder Cancer Recovery
53:59 - Conclusion: The Future of Bladder Cancer Treatment
Resources
Mark Cuban's Cost Plus Drug Company:
https://costplusdrugs.com/
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
Articles
Topics
